About
Awards
History
Leadership
Board of Directors
Investors and Partners
Pipeline
Cefepime-Taniborbactam
Ceftibuten-Ledaborbactam Etzadroxil
PBP Inhibitor
Publications
Manuscripts
Conference Presentations
News & Events
Press Releases
In the News
Events
Careers
Open Positions
#venatorxcares
Contact
Publications
Publications
Manuscripts
Conference Presentations
Manuscripts
Examining the activity of cefepime-taniborbactam against
Burkholderia cepacia
complex and
Burkholderia gladioli
isolated from cystic fibrosis patients in the United States
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-
β
-Lactamase-Positive Clinical Isolates of
Enterobacterales
from a 2018–2020 Global Surveillance Collection
MORE MANUSCRIPTS
Conference Presentations
In Vitro
Activity of Cefepime-Taniborbactamand Comparator Agents Against Gram-Negative Bacteria Isolated from Patients with Cancer
CERTAIN-1 Subgroup Analysis: A Phase 3 Study of Cefepime-Taniborbactam Efficacy and Safety in the Treatment of Complicated Urinary Tract Infections (cUTI)
Outcomes by Resistance Phenotype and Genotype among Baseline Pathogen in Patients with Complicated Urinary Tract Infection (cUTI) in the Phase 3 CERTAIN-1 Study
In vitro
activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactamagainst multi-species, NDM-producing Enterobacterales causing a local outbreak
MORE CONFERENCE PRESENTATIONS
You are using a browser that is not supported. Please consider changing your browser